Data gathered: January 30
AI Stock Analysis - Progyny (PGNY)
Analysis generated July 8, 2024. Powered by Chat GPT.
Progyny, Inc. is a leading benefits management company specializing in fertility and family building benefits solutions in the United States. The firm partners with employers to provide a comprehensive fertility benefits program through its network of specialized providers. As the fertility market continues to grow, Progyny's integrated approach and customizable solutions help it stand out in an increasingly competitive field.
Stock Alerts - Progyny (PGNY)
 |
Progyny | January 15 Josh Gottheimer (member of U.S. congress) is selling shares |
|
Progyny | January 13 Price is up by 6.9% in the last 24h. |
|
Progyny | January 7 Employee Rating is up by 3.3% over the last month. |
|
Progyny | January 7 Business Outlook among employees is up by 5.4% over the last month. |
Alternative Data for Progyny
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 31 | Sign up | Sign up | Sign up |
| Sentiment | 88 | Sign up | Sign up | Sign up |
| Webpage traffic | 141,000 | Sign up | Sign up | Sign up |
| Employee Rating | 64 | Sign up | Sign up | Sign up |
| Google Trends | 38 | Sign up | Sign up | Sign up |
| App Downloads | 55 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 7 | Sign up | Sign up | Sign up |
| Facebook Followers | 1,731 | Sign up | Sign up | Sign up |
| Instagram Followers | 5,522 | Sign up | Sign up | Sign up |
| Reddit Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 3 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,402 | Sign up | Sign up | Sign up |
| Twitter Followers | 2,087 | Sign up | Sign up | Sign up |
| Twitter Mentions | 19 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 8,590 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 60 | Sign up | Sign up | Sign up |
| Linkedin Employees | 675 | Sign up | Sign up | Sign up |
| NPS | 29 | Sign up | Sign up | Sign up |
About Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
| Price | $23.54 |
| Target Price | Sign up |
| Volume | 1,720,000 |
| Market Cap | $2.01B |
| Year Range | $13.67 - $30 |
| Dividend Yield | 0% |
| PE Ratio | 39.32 |
| Analyst Rating | 36% buy |
| Industry | Health Care Services |
In the news
 |
Progyny (NASDAQ:PGNY) Given New $23.00 Price Target at JPMorgan Chase & Co.January 30 - ETF Daily News |
|
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of “Hold” by BrokeragesJanuary 28 - ETF Daily News |
Progyny, Inc. Enhances Suite of Services with Acquisition of BenefitBumpJanuary 28 - GlobeNewswire |
|
|
Ballentine Partners LLC Invests $187,000 in Progyny, Inc. (NASDAQ:PGNY)January 26 - ETF Daily News |
Progyny Appoints Healthcare Veteran Debra Morris to Board of DirectorsJanuary 16 - GlobeNewswire |
|
|
FY2024 EPS Estimates for Progyny Boosted by Leerink PartnrsJanuary 15 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 287M | 274M | 59M | 10M | 12M | 0.400 |
| Q2 '24 | 304M | 283M | 68M | 16M | 21M | 0.170 |
| Q1 '24 | 279M | 260M | 62M | 17M | 19M | 0.170 |
| Q4 '23 | 271M | 256M | 57M | 13M | 14M | 0.130 |
| Q3 '23 | 282M | 263M | 63M | 16M | 19M | 0.160 |
Insider Transactions View All
| Schlanger David J filed to buy 228,269 shares at $14.7. December 26 '24 |
| Anevski Peter filed to buy 441,463 shares at $14.5. December 26 '24 |
| Payson Norman filed to sell 580,656 shares at $56.3. November 26 '21 |
| Sturmer Michael E filed to sell 362,583 shares at $30. July 18 '24 |
| Scott Cheryl filed to sell 10,098 shares at $28.4. July 1 '24 |
Similar companies
Read more about Progyny (PGNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Progyny?
The Market Cap of Progyny is $2.01B.
What is Progyny's PE Ratio?
As of today, Progyny's PE (Price to Earnings) ratio is 39.32.
What is the current stock price of Progyny?
Currently, the price of one share of Progyny stock is $23.54.
How can I analyze the PGNY stock price chart for investment decisions?
The PGNY stock price chart above provides a comprehensive visual representation of Progyny's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Progyny shares. Our platform offers an up-to-date PGNY stock price chart, along with technical data analysis and alternative data insights.
Does PGNY offer dividends to its shareholders?
As of our latest update, Progyny (PGNY) does not offer dividends to its shareholders. Investors interested in Progyny should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Progyny?
Some of the similar stocks of Progyny are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.